Lexeo Therapeutics, Inc.

8-K Shareholder vote results Jun 29, 2026 8-K Regulation FD disclosure; Other events Jun 15, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release); Other events May 11, 2026 8-K Director or officer change Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release); Other events Mar 30, 2026 8-K Director or officer change Feb 5, 2026 8-K Director or officer change Jan 27, 2026 8-K Regulation FD disclosure; Other events Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Other events Oct 17, 2025 8-K Regulation FD disclosure; Other events Oct 7, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Director or officer change Aug 14, 2025 8-K Shareholder vote results Jun 30, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 27, 2025 10-Q/A Quarter ended 2025-03-31 May 15, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Regulation FD disclosure; Other events Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Results of operations (earnings release) Mar 24, 2025 8-K Other events Jan 13, 2025 8-K Director or officer change Dec 19, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release); Director or officer change Nov 13, 2024 8-K Other events Oct 30, 2024 8-K Other events Oct 9, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Other events Jul 15, 2024 8-K Director or officer change; Other events Jul 8, 2024 8-K Shareholder vote results Jun 28, 2024 8-K Results of operations (earnings release) May 9, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Entered a material agreement; Other events Apr 22, 2024 8-K Director or officer change Apr 22, 2024 8-K Other events Apr 16, 2024